Delivery Order SPE2DB25D3202-SPE2DB25FTBEM
- Not listed
- The Defense Logistics Agency awarded a $9,728.17 delivery order to AmerisourceBergen Drug Corp for 120 tablets of Venclexta 100 mg on July 21, 2025, with an ultimate completion date of August 11, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded through an open process. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a $9,728.17 delivery order to AmerisourceBergen Drug Corp for Venclexta 100 mg tablets (120-count units) under a firm fixed-price contract. The order, issued on August 19, 2025, with completion targeted for September 10, 2025, represents a direct procurement of this specialized pharmaceutical product to support federal medical supply requirements. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor on this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Venclexta 100 mg tablets (quantity: 120 units) under a firm fixed-price contract valued at $9,728.17. This is a non-set-aside competitive award with an ultimate completion date of August 20, 2025, and performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Venclexta 100 mg tablets in quantities of 120 units. This firm fixed price delivery order, valued at $58,369.02, represents a non-competitive, non-set-aside award and is scheduled for completion by August 14, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its...
- The Defense Logistics Agency awarded a delivery order valued at $4,579.40 to AmerisourceBergen Drug Corp for 28 units of Venclexta 100 mg tablets. This contract, executed on August 8, 2025, with an ultimate completion date of August 29, 2025, represents a firm fixed price delivery order with no set-aside designation. The order will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This award is issued as a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $9,728.17 to supply Venclexta 100 mg tablets (120-count units) with an ultimate completion date of September 9, 2025. This is a firm fixed-price, non-set-aside delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical products will be delivered to...
- The Defense Logistics Agency awarded a $4,579.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for VENCLEXTA 100 mg tablets (28-count units) on July 30, 2025, with an ultimate completion date of August 20, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. Performance of this delivery order is based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Venclexta 100 mg tablets (120-count units) with a contract ceiling value of $9,728.17. This is a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 29, 2025, for the supply of Venclexta 100 mg tablets in a quantity of 120 units. This competitive award, valued at $9,728.17 with a firm fixed price structure, is scheduled for completion by August 19, 2025. The order will be fulfilled from the vendor's Conshohocken facility, supporting the federal government's pharmaceutical supply chain...
- This delivery order awards $11,826.42 to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets (120-count units), with an ultimate completion date of August 14, 2025. The contract was competitively awarded without set-aside provisions and employs firm fixed-price terms. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is performing this order from its corporate office location in the same city. The Defense Logistics Agency, operating under the Department of...
- SPE2DB25D3202Indefinite Delivery Contract
- SPE2DB25D3202-SPE2DB25FTBEMDelivery Order
The Defense Logistics Agency awarded a competitively-bid delivery order valued at $2,289.70 to AmerisourceBergen Drug Corp for 28-tablet units of Venclexta 100 mg tablets, with completion targeted for September 11, 2025. This non-set-aside contract represents a firm fixed price transaction for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order operates as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support, enabling the contractor to supply a broad range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide, including services to the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 8/20/25 |